NEW YORK (GenomeWeb News) – Investment bank Piper Jaffray has upgraded its rating on Becton Dickinson's stock to Overweight and increased its price target.

Analyst William Quirk cited increased interest in microbiology diagnostic systems and BD's position in the market in a research note explaining the upgrade. In addition, he said BD could be poised to gain market share following a recent recall by Siemens of its MicroScan microbiology testing panels in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.